Apogee Therapeutics (APGE) Other Accumulated Expenses (2022 - 2024)

Apogee Therapeutics (APGE) has 3 years of Other Accumulated Expenses data on file, last reported at $1.7 million in Q3 2024.

• On a quarterly basis, Other Accumulated Expenses rose 144.65% year-over-year to $1.7 million in Q3 2024; TTM through Sep 2024 was $1.7 million, a 144.65% increase from a year earlier, with the FY2023 full-year figure at $1.2 million, up 521.5% from the prior year.
• Other Accumulated Expenses for Q3 2024 stood at $1.7 million, up from $1.0 million in the prior quarter.
• Over the last five years, Other Accumulated Expenses for APGE reached as high as $2.1 million in Q1 2024 and fell as low as $200000.0 in Q4 2022.
• Historically, Other Accumulated Expenses has averaged $1.3 million across 3 years, with a median of $1.2 million in 2023.
• Across the five-year window, Other Accumulated Expenses jumped 521.5% in 2023 and tumbled 44.94% in 2024, its largest moves.
• Year by year, Other Accumulated Expenses stood at $200000.0 in 2022, then soared by 521.5% to $1.2 million in 2023, then jumped by 36.2% to $1.7 million in 2024.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $1.7 million in Q3 2024, $1.0 million in Q2 2024, and $2.1 million in Q1 2024.